Related Experiment Video

Updated: Dec 29, 2025

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

457

5-year safety of TAVI in intermediate-risk patients

Gregory B Lim1

  • 1Nature Reviews Cardiology, . nrcardio@nature.com.

Nature Reviews. Cardiology
|February 8, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.1K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.1K

Related Experiment Videos

Last Updated: Dec 29, 2025

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

457
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.1K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.1K

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

288
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
288
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

190
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
190

Articles linked to this work by shared authors, journal, and citation graph.

The role of hypoxia-inducible factors in myocardial ischaemia-reperfusion injury and cardioprotection.

Nature reviews. Cardiology·2026

Intracoronary imaging in percutaneous coronary intervention: why, when, how and which from large, randomized trials.

Nature reviews. Cardiology·2026

Dyslipidaemia and hepatic steatosis: mechanisms and implications for lipid-lowering therapy.

Nature reviews. Cardiology·2026

Nicotine-containing products and the cardiovascular system: mechanisms and global health implications.

Nature reviews. Cardiology·2026

Cardiac fibroblast diversity in HFpEF: states, niches, interorgan drivers and targets.

Nature reviews. Cardiology·2026

Haemolytic injury and cardiovascular disease.

Nature reviews. Cardiology·2026

Prevalence of noncanonical virulence factors in the adherence and invasion by enterotoxigenic Escherichia coli in the small and large intestines.

Frontiers in cellular and infection microbiology·2026

Greener active pharmaceutical ingredients: perspectives of European healthcare professionals.

BMC health services research·2026

MFN2-mediated remodelling of ER-mitochondria communication alleviates ochratoxin A-induced hepatocyte ferroptosis by enhancing mitophagy.

Journal of hazardous materials·2026

EPHA3, upregulated in high-risk histological subtypes of gastrointestinal stromal tumor, promotes GIST progression.

Radiology and oncology·2026

One Health prescribing - development of enantioselective liquid chromatography - tandem mass spectrometry methods to inform chiral switch of prescription pharmaceuticals.

Analytical methods : advancing methods and applications·2026

In vitro potency of novel ertapenem/zidebactam combination (WCK 6777) against carbapenemase-producing Enterobacterales collected across India.

JAC-antimicrobial resistance·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us